blincyto
amgen europe b.v. - blinatumomab - vorläuferzelle lymphoblastische leukämie-lymphom - antineoplastische mittel - blincyto is indicated as monotherapy for the treatment of adults with cd19 positive relapsed or refractory b precursor acute lymphoblastic leukaemia (all). patients with philadelphia chromosome positive b-precursor all should have failed treatment with at least 2 tyrosine kinase inhibitors (tkis) and have no alternative treatment options. blincyto is indicated as monotherapy for the treatment of adults with philadelphia chromosome negative cd19 positive b-precursor all in first or second complete remission with minimal residual disease (mrd) greater than or equal to 0. blincyto is indicated as monotherapy for the treatment of paediatric patients aged 1 year or older with philadelphia chromosome negative cd19 positive b precursor all which is refractory or in relapse after receiving at least two prior therapies or in relapse after receiving prior allogeneic haematopoietic stem cell transplantation. blincyto is indicated as monotherapy for the treatment of paediatric patients aged 1 year or older with high-risk first relapsed philadelphia chromosome negative cd19 positive b-precursor all as part of the consolidation therapy (see section 4.
mama natura dormi tablette
schwabe pharma belgium (afgekort schwabe) - zincum valerianicum; magnesium carbonicum; cypripedium pubescens - tablette - zincum valerianicum ; magnesium carbonicum; cypripedium pubescens
blincyto 38.5 mcg pulver für ein konzentrat zur herstellung einer infusionslösung
amgen switzerland ag - blinatumomabum - pulver für ein konzentrat zur herstellung einer infusionslösung - praeparatio cryodesiccata: blinatumomabum 38.5 µg, acidum citricum monohydricum, trehalosum dihydricum, lysini hydrochloridum, polysorbatum 80, natrii hydroxidum, pro vitro corresp. natrium 1.5 mg. solvens: acidum citricum monohydricum, lysini hydrochloridum, polysorbatum 80, natrii hydroxidum, aqua ad iniectabile q.s. ad solutionem pro 10 ml corresp. natrium 18.35 mg. - onkologikum - biotechnologika
prick-testlösung meerschweinchenhaare
bencard allergie gmbh (8023035) - meerschweinchenhaar-allergen - pricktestlösung - meerschweinchenhaar-allergen (38229) 6 prozentgehalt masse (gewicht) in volumen
senstend
plethora pharma solutions limited - lidocaine, prilocaine - vorzeitige ejakulation - anästhetika - senstend ist indiziert für die behandlung der primären vorzeitigen ejakulation bei erwachsenen männern.
cufence
univar solutions bv - trientine dihydrochloride - hepatolentikuläre degeneration - anderen verdauungstrakt und stoffwechsel-produkte, - cufence ist indiziert für die behandlung des morbus wilson bei patienten, die intolerant gegenüber d-penicillamin-therapie bei erwachsenen und kindern im alter von 5 jahren oder älter.
nervoheel tablette
heel belgium - phosphoricum acidum; ignatia amara; sepia officinalis; kalium bromatum; zincum valerianicum - tablette - phosphoricum acidum; ignatia amara; sepia officinalis; kalium bromatum; zincum valerianicum
ticagrelor elpen 60 mg filmtabletten
elpen pharmaceutical co. inc. beiname: elpen, elpen s.a., elpen a.e. (8066783) - ticagrelor - filmtablette - 60 mg - ticagrelor (34029) 60 milligramm